Erratum to: Effect of VKORC1, CYP2C9, CYP4F2, and GGCX Gene Polymorphisms on Warfarin Dose in Japanese Pediatric Patients

被引：0
|
作者：
Takuya Wakamiya
Tatsunori Hokosaki
Shin-ichi Tsujimoto
Keisuke Kadota
Yusuke Nakano
Shigeo Watanabe
Mari Iwamoto
Masakatsu Yanagimachi
Shuichi Ito
机构：
[1] Yokohama City University School of Medicine,Department of Pediatrics
来源：
Molecular Diagnosis & Therapy | 2016年 / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：501 / 501
相关论文
共 50 条
  • [41] THE INFLUENCE OF CYP2C9 AND VKORC1 GENE POLYMORPHISMS ON THE RESPONSE TO WARFARIN IN EGYPTIANS
    Bedewy, A.
    Kandil, L.
    Showeta, Salah
    Hasan, M.
    THROMBOSIS RESEARCH, 2016, 141 : S68 - S69
  • [42] Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX
    Fohner, Alison E.
    Robinson, Renee
    Yracheta, Joseph
    Dillard, Denise A.
    Schilling, Brian
    Khan, Burhan
    Hopkins, Scarlett
    Boyer, Bert B.
    Black, Jynene
    Wiener, Howard
    Tiwari, Hemant K.
    Gordon, Adam
    Nickerson, Deborah
    Tsai, Jesse M.
    Farin, Federico M.
    Thornton, Timothy A.
    Rettie, Allan E.
    Thummel, Kenneth E.
    PHARMACOGENETICS AND GENOMICS, 2015, 25 (07): : 343 - 353
  • [43] The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians
    Bedewy, Ahmed M. L.
    Showeta, Salah
    Mostafa, Mostafa Hasan
    Kandil, Lamia Saeed
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (02) : 328 - 336
  • [44] Frequency of polymorphisms in the CYP2C9, VKORC1, and CYP4F2 genes related to the metabolism of Warfarin in healthy donors from Cali, Colombia
    Giraldo-Ocampo, Sebastian
    Diaz-Ordonez, Lorena
    Silva-Cuero, Yisther Katherine
    Gutierrez-Medina, Juan David
    Candelo, Estephania
    Diaz, Javier A.
    Pachajoa, Harry
    MEDICINE, 2023, 102 (30) : E34204
  • [45] Resequencing of VKORC1, CYP2C9 and CYP4F2 genes in Italian patients requiring extreme low and high warfarin doses
    Di Fusco, Davide
    Ciccacci, Cinzia
    Rufini, Sara
    Forte, Vittorio
    Novelli, Giuseppe
    Borgiani, Paola
    THROMBOSIS RESEARCH, 2013, 132 (01) : 123 - 126
  • [46] Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
    Rusdiana, T.
    Araki, T.
    Nakamura, T.
    Subarnas, A.
    Yamamoto, K.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (03) : 395 - 405
  • [47] A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
    Takeuchi, Fumihiko
    McGinnis, Ralph
    Bourgeois, Stephane
    Barnes, Chris
    Eriksson, Niclas
    Soranzo, Nicole
    Whittaker, Pamela
    Ranganath, Venkatesh
    Kumanduri, Vasudev
    McLaren, William
    Holm, Lennart
    Lindh, Jonatan
    Rane, Anders
    Wadelius, Mia
    Deloukas, Panos
    PLOS GENETICS, 2009, 5 (03):
  • [48] Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population
    T. Rusdiana
    T. Araki
    T. Nakamura
    A. Subarnas
    K. Yamamoto
    European Journal of Clinical Pharmacology, 2013, 69 : 395 - 405
  • [49] Effect of CYP2C9 and VKORC1 genetic polymorphism on Warfarin dose requirement
    Ashavaid, T. F.
    Ponde, C. K.
    Raghavan, R.
    Kapadia, F. N.
    Shah, S. A.
    Natarajan, S.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 508
  • [50] VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study
    Zambon, Carlo-Federico
    Pengo, Vittorio
    Padrini, Roberto
    Basso, Daniela
    Schiavon, Stefania
    Fogar, Paola
    Nisi, Alessandra
    Frigo, Anna Chiara
    Moz, Stefania
    Pelloso, Michela
    Plebani, Mario
    PHARMACOGENOMICS, 2011, 12 (01) : 15 - 25
12345